Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed) (NCT07576647) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)
Canada1,600 participantsStarted 2026-04
Plain-language summary
Stroke is a major health issue, especially for women, who are more likely than men to have worse outcomes and lower quality of life after a stroke. Yet, women are under-represented in stroke research, which limits how well treatments work for them. This study aims to change that by testing a new way to recruit women into stroke research using the ORDER toolkit, a set of easy-to-understand, women-focused materials like brochures and videos co-designed with patients. This new approach will be compared to the usual way of recruiting patients. The study will track how many people join, how long it takes to make a decision, and what influences participation. Patients and research coordinators will also share their feedback on the process. Our goal is to make stroke studies more inclusive so that research findings benefit everyone equally.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participants eligible for StrokeGoRed hospitalized cohort are eligible for ORDERed:
Inclusion Criteria:
* All patients, regardless of age or baseline disability, seen in urgent TIA/stroke clinics and referred from the emergency department for suspected TIA or minor stroke will be included over one calendar year
Exclusion Criteria:
* There are no exclusion criteria
Participants eligible for StrokeGoRed hospitalized cohort are eligible for ORDERed:
Inclusion Criteria:
* Ischemic stroke
* Intracerebral hemorrhage
Exclusion Criteria:
* Cerebral venous thrombosis
* Subarachnoid hemorrhage
* Subdural hemorrhage
* Intracranial hemorrhage due to trauma or underlying mass
* Clinical transient ischemic attack without evidence of infarct on neuroimaging
* Imaging abnormality (e.g., dissection, carotid stenosis, vessel irregularity) without imaging or clinical evidence of stroke
* Stroke that occurred while being admitted for another reason
* Stroke that started more than 14 days prior to admission
* Stroke initially treated outside of Canada
* Stroke where inpatient stroke or neurology service was not consulted
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is described as focusing on equitable recruitment into stroke research — does that mean it's studying how people like me get enrolled in studies, rather than testing a new treatment for my stroke or TIA, and if so, what would my actual participation involve?
2Since this trial isn't recruiting yet, how soon do you expect it to open, and should I be making my current treatment decisions now rather than waiting to see if this becomes available?
3The trial seems to be measuring enrollment rates and barriers to research participation — would joining this study have any direct impact on the medical care or treatment I receive for my stroke or TIA, or is it purely about improving how future research is done?
4Given that this is listed as 'Phase NA,' which suggests it may be more of an observational or process-improvement study rather than a drug or device trial, can you help me understand what the risks and time commitments of participating might actually look like for me?
5Are there standard treatment guidelines or other active clinical trials for my stroke or TIA that I should be focusing on first, while this study is still in the pre-recruitment phase?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Effectiveness - Enrollment rate
Timeframe: From initial contact with study coordinator to decision to participate (up to 30 days)
2
Effectiveness - Efficiency
Timeframe: From initial contact with study coordinator to decision to participate (up to 30 days)
3
Barriers and Facilitators
Timeframe: At time of enrollment decision to the StrokeGoRed study (consent or decline)